Navigation Links
Experimental vaccine protects monkeys against chikungunya
Date:3/4/2010

GALVESTON, Texas Imagine a mosquito-borne virus that has already infected millions of people in recent outbreaks in South and Southeast Asia, the islands of the Indian Ocean, Africa and northern Italy. Although seldom fatal, it causes highly painful arthritis-like symptoms that can linger for months or even years. It's capable of adapting to spread through a mosquito species common in much of North America. And no vaccine or treatment exists to protect humans from its effects.

The scenario may sound like something dreamed up as a training exercise by public health authorities, but the virus is all too real. Called chikungunya, from an East African tribal word describing the contorted postures of its pain-wracked victims, the pathogen has been the focus of intense scientific interest ever since a 2006 outbreak on the island of La Reunion in the Indian Ocean infected about 266,000 people, killing 260 of them.

Now, researchers at the National Institute of Allergy and Infectious Diseases, the University of Texas Medical Branch at Galveston, Purdue University and Bioqual Inc. have developed an experimental vaccine for chikungunya virus and successfully tested it in monkeys. Described in a paper appearing in the March issue of Nature Medicine, the vaccine is composed of noninfectious "virus-like particles." Although coated with the same proteins that enable chikungunya to pass through cell membranes, the vaccine particles lack the proteins that chikungunya uses to replicate inside cells. They look like chikungunya to the immune systems of rhesus macaques, however, which respond to exposure by generating antibodies that defend the monkeys from infection by the real virus.

"This vaccine did an excellent job of protecting the macaques from chikungunya," said UTMB professor Stephen Higgs, one of the paper's authors. "That it worked so well in a primate model is good news these macaques are quite similar to humans in their response to c
'/>"/>

Contact: Jim Kelly
jpkelly@utmb.edu
409-772-8791
University of Texas Medical Branch at Galveston
Source:Eurekalert

Page: 1 2

Related biology news :

1. Experimental drug shows promise against brain, prostate cancers
2. French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 2009
3. Experimental treatments restore partial vision to blind people
4. Experimental treatment halts hypoxic-ischemic brain injury in newborns
5. 40 minority scientists receive travel fellowships to Experimental Biology 2009 in New Orleans
6. Survival in a Changing World: The Journal of Experimental Biology 2009 symposium
7. French scientist wins the Journal of Experimental Biology Outstanding Paper Prize
8. Experimental chemotherapy regimen shows promise in treating advanced lung cancer
9. Experimental Biology and Medicine announces expansion into Asia, opens new office
10. Translational research patented first experimental treatment against idiopathic pulmonary fibrosis
11. Experimental Biology 2008 meets in San Diego April 5-9
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... proteins to survive in the icy Southern Ocean ... by the National Science Foundation (NSF) report: The ... resist melting even when temperatures warm. , ... consequence of the evolution of antifreeze proteins in ... student Paul Cziko, who led the research with ...
(Date:9/23/2014)... the body forms new tissues during the healing ... each other. For years, scientists believed this communication ... Carnegie Mellon University and the University of Pittsburgh ... is equally if not more crucial. The ... Proceedings of the National Academy of Sciences ...
(Date:9/23/2014)... have scoured cow rumens and termite guts for microbes ... the production of next-generation biofuels, but some of the ... lower intestine, researchers report. , Their study , ... of Sciences , is the first to use biochemical ... human gut can digest fiber, breaking it down into ...
Breaking Biology News(10 mins):Antifreeze proteins in Antarctic fish prevent both freezing and melting 2Antifreeze proteins in Antarctic fish prevent both freezing and melting 3The mechanics of tissue growth 2Search for better biofuels microbes leads to the human gut 2Search for better biofuels microbes leads to the human gut 3
... Liver transplant patients with hepatitis C virus (HCV) ... the immunosuppressive agent Cyclosporine along with interferon-ribavirin combination ... virus in vitro. , The results of ... of Liver Transplantation, the official journal of the ...
... infants born with HIV infection may be most effective ... according to a study published in the April 1 ... online. , Uncertainty over when to start antiretroviral treatment ... around balancing the benefits of preventing disease progression and ...
... in which single strands of synthetic DNA are used ... been developed by researchers with the Lawrence Berkeley National ... Berkeley. This technique holds promise for a wide ... of artificial tissues and the design of neural networks. ...
Cached Biology News:Cyclosporine inhibits hepatitis C virus in vitro 2New study shows benefit of early therapy in HIV-infected infants 2Berkeley researchers lay groundwork for cell version of DNA chip 2Berkeley researchers lay groundwork for cell version of DNA chip 3Berkeley researchers lay groundwork for cell version of DNA chip 4
(Date:9/23/2014)... , Sept. 23, 2014 News ... India devoted to genome-based research for ... Genomics (NIBMG) is taking a bite out of oral ... among males in India with the ... solutions from DataDirect Networks (DDN). , To fuel its ...
(Date:9/23/2014)... WASHINGTON, New York , September 23, 2014 ... ), a leading provider of  Closed System Transfer   ... a new exclusive partnership with Taiwanese distributor MedFront Medical Technology ... regulatory bodies in Taiwan , ... for approval as the company continues to expand ...
(Date:9/23/2014)... September 23, 2014 The Minnesota ... developer of cellular modems , platforms and ... the Startup category for the 2014 Tekne Awards. ... at the Minneapolis Convention Center on Thursday, November ... individuals who have shown superior technology innovation and ...
(Date:9/22/2014)... 2014 Research and Markets ... the "Global Biotechnology Reagents Market 2014-2018" ... http://photos.prnewswire.com/prnh/20130307/600769) Biotechnology reagents are chemical compounds ... to detect and examine another substance to provide ... laboratories to prepare, collect, and examine specimens from ...
Breaking Biology Technology:National Institute of Biomedical Genomics (NIBMG) Deploys DataDirect Networks Storage to Achieve Significant Performance Improvement in World-Class Genomics Research and Collaboration for Oral Cancer 2National Institute of Biomedical Genomics (NIBMG) Deploys DataDirect Networks Storage to Achieve Significant Performance Improvement in World-Class Genomics Research and Collaboration for Oral Cancer 3National Institute of Biomedical Genomics (NIBMG) Deploys DataDirect Networks Storage to Achieve Significant Performance Improvement in World-Class Genomics Research and Collaboration for Oral Cancer 4National Institute of Biomedical Genomics (NIBMG) Deploys DataDirect Networks Storage to Achieve Significant Performance Improvement in World-Class Genomics Research and Collaboration for Oral Cancer 5Equashield Enters Taiwan Following Expansion to Australia, Japan, China 2NimbeLink Named Finalist for 15th Annual Tekne Awards 2NimbeLink Named Finalist for 15th Annual Tekne Awards 3Global Biotechnology Reagents Market 2014-2018: Key Vendors are Agilent, BD Biosciences, Bio-Rad, F. Hoffmann-La Roche, Sigma-Aldrich and Thermo Fisher 2Global Biotechnology Reagents Market 2014-2018: Key Vendors are Agilent, BD Biosciences, Bio-Rad, F. Hoffmann-La Roche, Sigma-Aldrich and Thermo Fisher 3
... GeoVax Labs, Inc. (OTC,Bulletin Board: GOVX), an Atlanta-based biotechnology ... an,operational update for the quarter ended June 30, 2007. ... 2007 The Company recorded a net loss of ... to net income of $197,750 for the same period,in ...
... Transgenomic, Inc. (the,"Company") (OTC Bulletin Board: TBIO) today ... The Company,s financial results are,presented in the tables that ... a net profit of $0.2 million or $0.00 per ... a net loss of $0.4 million or,$0.01 per share ...
... Martek Biosciences,Corporation announced that it intends to release ... September 5, 2007, at approximately 4:00 p.m.,Eastern Daylight Time ... hold a conference call to discuss the results of ... is expected to be approximately one,hour in duration. The ...
Cached Biology Technology:GeoVax Labs, Inc. Second Quarter Financial Results and Operational Update 2GeoVax Labs, Inc. Second Quarter Financial Results and Operational Update 3GeoVax Labs, Inc. Second Quarter Financial Results and Operational Update 4GeoVax Labs, Inc. Second Quarter Financial Results and Operational Update 5GeoVax Labs, Inc. Second Quarter Financial Results and Operational Update 6Transgenomic, Inc. Reports Second Quarter 2007 Results 2Transgenomic, Inc. Reports Second Quarter 2007 Results 3Transgenomic, Inc. Reports Second Quarter 2007 Results 4Transgenomic, Inc. Reports Second Quarter 2007 Results 5Transgenomic, Inc. Reports Second Quarter 2007 Results 6Transgenomic, Inc. Reports Second Quarter 2007 Results 7Transgenomic, Inc. Reports Second Quarter 2007 Results 8Martek to Announce Third Quarter 2007 Results on September 5, 2007 2
...
Recalibration of HL-2000-CAL products...
Mature rat whole blood (Sprague-Dawley, averaging 7-8 weeks of age, either sex) is collected at the time of slaughter and processed within 45 minutes. It is then filtered through gauze, pooled in an ...
Several Pichia pastoris strains are available to allow you to optimize expression and recovery of your protein of interest. Table 1 provides information to help you choose the appropriate strain....
Biology Products: